Phosphodiesterase inhibitors, congestive heart failure, and sudden death: time for re-evaluation.
about
Histone deacetylase signaling in cardioprotectionβ2 adrenergic receptor activation governs cardiac repolarization and arrhythmogenesis in a guinea pig model of heart failureAdditional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.Tadalafil prevents acute heart failure with reduced ejection fraction in mice.
P2860
Phosphodiesterase inhibitors, congestive heart failure, and sudden death: time for re-evaluation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@en
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@nl
type
label
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@en
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@nl
prefLabel
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@en
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@nl
P2093
P2860
P1476
Phosphodiesterase inhibitors, ...... death: time for re-evaluation.
@en
P2093
Amit Varma
Keyur B Shah
Michael L Hess
P2860
P304
P356
10.1111/J.1751-7133.2012.00293.X
P577
2012-04-16T00:00:00Z